Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic tranexamic acid for perioperative blood loss in robotic-assisted radical prostatectomy
TCTR20260813009Phase 3Not yet recruiting
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in prostate cancer (PCa), sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on TCTR20260813009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260813009.